CAV1 and prostate neoplasm: Orthotopic prostate tumour xenografts of Cav-1-secreting cells (RM-9) in Cav-1 gene-disrupted mice or their wild type counterparts revealed that the mean tumour weight and microvessel densities in Cav-1(+/+) mice were higher than Cav-1(−/−) mice [23].